Merck commits to Veeva Vault CRM for commercial operations

Merck (NYSE: MRK) has committed to implementing Veeva Systems' (NYSE: VEEV) Vault CRM solution to support its commercial operations during what the company describes as one of its most significant product launch periods, according to a statement from Veeva Systems.

The pharmaceutical company, known as MSD outside the United States and Canada, will use the CRM platform as it prepares to launch products across new therapeutic areas and treatment modalities.

"We are excited to expand our strategic partnership with Veeva by moving to Vault CRM," said Dave Williams, executive vice president and chief information and digital officer at Merck. "We share a deep commitment to customer success, and Vault CRM will provide Merck the technology foundation to drive commercial execution."

Peter Gassner, CEO of Veeva Systems, stated that the company is "honored to be a strategic partner to Merck and it is great to see our partnership extend to Vault CRM."

Vault CRM is part of Veeva's CRM Suite, which the company describes as applications designed for commercial execution across personal and digital channels. The platform includes global capabilities intended to address regional and country-specific business and compliance requirements in the pharmaceutical industry.

Veeva Systems provides cloud software solutions for the life sciences industry and serves more than 1,000 customers, ranging from large biopharmaceutical companies to emerging biotechnology firms. The company operates as a Public Benefit Corporation.

You May Also Be Interested In